HeimTWST • NASDAQ
add
Twist Bioscience Corp
43,34 $
Eftir lokun(0,00%)0,00
43,34 $
Lokað: 4. okt., 16:02:11 GMT-4 · USD · NASDAQ · Lagalegir fyrirvarar
Við síðustu lokun
42,79 $
Dagbil
43,17 $ - 44,54 $
Árabil
14,43 $ - 60,90 $
Markaðsvirði
2,54 ma. USD
Meðalmagn
745,63 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
NASDAQ
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | jún. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 81,46 m. | 27,81% |
Rekstrarkostnaður | 79,26 m. | 12,29% |
Nettótekjur | -85,57 m. | -49,09% |
Hagnaðarhlutfall | -105,04 | -16,65% |
Hagnaður á hvern hlut | -0,70 | 31,23% |
EBITDA | -35,69 m. | 11,22% |
Virkt skatthlutfall | -0,22% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | jún. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 289,42 m. | -18,96% |
Heildareignir | 638,12 m. | -21,25% |
Heildarskuldir | 146,98 m. | -3,80% |
Eigið fé alls | 491,14 m. | — |
Útistandandi hlutabréf | 58,59 m. | — |
Eiginfjárgengi | 5,10 | — |
Arðsemi eigna | -16,40% | — |
Ávöxtun eigin fjár | -17,91% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | jún. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | -85,57 m. | -49,09% |
Handbært fé frá rekstri | -6,38 m. | 72,76% |
Reiðufé frá fjárfestingum | -711,00 þ. | -103,81% |
Reiðufé frá fjármögnun | 2,91 m. | 539,94% |
Breyting á handbæru fé | -4,18 m. | 26,98% |
Frjálst peningaflæði | 6,02 m. | 464,11% |
Um
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Framkvæmdastjóri
Stofnsett
2013
Vefsvæði
Starfsfólk
919
